Capital Guardian Trust’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Capital Guardian Trust's BMY Position: Q4 2017 in Review
Capital Guardian Trust sold out of Bristol-Myers Squibb (BMY) in Q4 2017, closing a stake of 800 shares — an estimated $51K sold.
Capital Guardian Trust first reported a position in BMY in Q2 2013 and held it in 17 quarters. The position peaked at $414M in Q4 2013. 1,736 funds tracked by Wall St. Rank hold BMY as of Q4 2017.
- Capital Guardian Trust reported no remaining Bristol-Myers Squibb position as of Q4 2017 after selling out during the quarter.
- Capital Guardian Trust sold 800 Bristol-Myers Squibb shares in Q4 2017, an estimated $51K.
- Capital Guardian Trust first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 17 quarters.
- Capital Guardian Trust's Bristol-Myers Squibb position peaked at $414M in Q4 2013.
- 1,736 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2017.
Based on Capital Guardian Trust's 13F filing for Q4 2017, filed 14 Feb 2018.